Anti-androgenic activity of Nardostachys jatamansi DC and Tribulus terrestris L. and their beneficial effects on polycystic ovary syndrome-induced rat models

Metabolic Syndrome and Related Disorders

Volumn 13, Issue 6, 2015, Pages 248-254

  Sandeep, Palakkil Mavilavalappil ^a   Bovee, Toine F H ^b   Sreejith, Krishnan ^a  

^a KANNUR UNIVERSITY   (India)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ANTIANDROGEN; CYPERUS ROTUNDUS EXTRACT; EMBELIA TSJERIAM COTTAM EXTRACT; ESTRADIOL; ESTRADIOL VALERATE; FLUTAMIDE; HELICTERES ISORA EXTRACT; NARDOSTACHYS JATAMANSI EXTRACT; PLANT EXTRACT; PROGESTERONE; SYMPLOCOS RACEMOSA EXTRACT; TESTOSTERONE; TRIBULUS TERRESTRIS EXTRACT; UNCLASSIFIED DRUG; WITHANIA SOMNIFERA EXTRACT; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANDROGEN THERAPY; ARTICLE; BIOASSAY; CONTROLLED STUDY; CORPUS LUTEUM; DRUG EFFICACY; DRUG MEGADOSE; EMBELIA; EMBELIA TSJERIAM COTTAM; ESTRADIOL BLOOD LEVEL; FEMALE; FLUORESCENCE; FOLLICLE CYST; HELICTERES ISORA; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RAT; SYMPLOCOS RACEMOSA; TESTOSTERONE BLOOD LEVEL; TRIBULUS TERRESTRIS; VAGINA SMEAR; VALERIANA JATAMANSI; WEIGHT GAIN; WITHANIA SOMNIFERA; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ESTRUS CYCLE; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; NARDOSTACHYS; OVARY FOLLICLE; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; POLYCYSTIC OVARY SYNDROME; SPRAGUE DAWLEY RAT; TIME FACTOR; TRIBULUS;

ANDROGEN ANTAGONISTS; ANIMALS; BIOMARKERS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROUS CYCLE; FEMALE; NARDOSTACHYS; OVARIAN FOLLICLE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; RATS, SPRAGUE-DAWLEY; TESTOSTERONE; TIME FACTORS; TRIBULUS; WEIGHT GAIN;

EID: 84937577763     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2014.0136     Document Type: Article

References (18)

1. Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191.
2. Shannon M, Wang Y. Polycystic ovary syndrome: A common but often unrecognized condition. J Midwifery Womens Health 2012; 57:221-230.
3. Torre A, Fernandez H. [Polycystic ovary syndrome (PCOS)]. J Gynecol Obstet Biol Reprod (Paris) 2007; 36:423-146.
4. Brogden RN, Clissold SP. Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer. Drugs 1989; 38:185-203.
5. Venturoli S, Fabbri R, Dal Prato L, et al., Ketoconazole therapy for women with acne and/or hirsutism. J Clin Endocrinol Metab 1990; 71:335-339.
6. Gormley G. One-year experience in the treatment of benign prostatic hyperplasia with finasteride. The MK-906 (Finasteride) Study Group. J Androl 1991; 12:372-375.
7. Kuusi T, Nikkila EA, Tikkanen MJ, et al. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2. Atherosclerosis 1985; 54:251-262.
8. Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod 2012; 86:149.
9. Raja-Khan N, Stener-Victorin E, Wu X, et al. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab 2011; 301:E1-E10.
10. Wachtel-Galor S, Benzie IFF. Herbal medicine: An introduction to its history, usage, regulation, current trends, and research needs. In: Benzie IFF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. Boca Raton FL: CRC Press, 2011.
11. Bovee TF, Helsdingen RJ, Hamers AR, et al. A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists. Anal Bioanal Chem 2007; 389:1549-1558.
12. Bovee TFH, Bor G, Becue I, et al. Inter-laboratory comparison of a yeast bioassay for the determination of estro-genic activity in biological samples. Anal Chim Acta 2009; 637:265-272.
13. Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: Some helpful considerations. Braz J Biol 2002; 62:609-614.
14. Lara HE, Ferruz JL, Luza S, et al. Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 1993; 133:2690-2695.
15. Dehghan A, Esfandiari A, Bigdeli SM. Alternative treatment of ovarian cysts with Tribulus terrestris extract: A rat model. Reprod Domest Anim 2012; 47:e12-e15.
16. Brawer JR, Naftolin F, Martin J, et al. Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology 1978; 103:501-512.
17. Stener-Victorin E, Lundeberg T, Waldenstrom U, et al. Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biol Reprod 2000; 63:1497-1503.
18. Morales-Ledesma L, Linares R, Rosas G, et al. Unilateral sectioning of the superior ovarian nerve of rats with poly-cystic ovarian syndrome restores ovulation in the innervated ovary. Reprod Biol Endocrinol 2010; 8:99.